PARVULET
Table of contents:
| Trademark domain | |
| name | is free? |
|---|---|
| parvulet.com |  |
The "PARVULET" trademark, serial number 78705641 , was filed on 1st of September 2005 with a mark drawing code of 4000 and its transaction date is 78705641. The attorney assigned is Dianne M. Lambillotte, attorney docket number 7920244292-U. Since 29th of August 2012, the document can be found in the M40 law office in the publication and issue section. The employee responsible is KEARNEY, COLLEEN and the date it was published for opposition on 06/02/2009. The date when we last checked the status of this trademark was 08/15/2012.
The corresponded responsible for this trademark is DAVID O. JOHANSON, located at BINGHAM MCCUTCHEN LLP, ONE FEDERAL STREET, BOSTON, MA 02110.The state or country where the trademark was organized is by Egalet Ltd. The legal entity type behing it is a Corporation, located at Egmont House, 8 Clifford Street, London, zip W1S 2LQ and also by Egalet A/s - Corporation, located at Lejrvej 39-41, Kirke Værløse, zip 3500.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 09/09/2005 |
| Primary Code | 005 |
| International Class - 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. | |
| U.S. Class | 044 - Dental, Medical, and Surgical Appliances |
| Class Status | 6 - Active |
| Status Date | 09/09/2005 |
| Primary Code | 010 |
| International Class - 040 - Treatment of materials. | |
| U.S. Class | 106 - Material Treatment |
| Class Status | 6 - Active |
| Status Date | 09/09/2005 |
| Primary Code | 040 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 09/09/2005 |
| Primary Code | 042 |
| Goods codes | |
| GS0051 | Pharmaceutical and veterinary preparations for the treatment of pain relief and pain management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases in the nature of flu, AIDS/HIV, anthrax, plague, cholera, biological infections, and prion exposure, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, genitourinary diseases and afflictions, premature labor, poison exposure, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; dietetic food adapted for medical use; diagnostic preparations for medical and veterinary use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; synthetic peptides for pharmaceutical purposes; vitamins; biomedical compounds, namely, peptide substrates for use in analyzing and detecting toxins for medical laboratory use; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets, oral liquids, oral gels, and oral emulsions for the continuous release of a wide variety of therapeutic agents within a certain time after ingestion; medicated candy; medicated chewing gum; breath-freshening chewing gum for medical purposes; medicated lollipops; sweets for medicinal purposes, namely, sweets containing pharmaceutical and medical substances and compounds |
| GS0101 | Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, emulsions, blister packs and sachets; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems |
| GS0401 | Treatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials |
| GS0421 | Scientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; chemical, biochemical, biological and bacteriological research and analysis; pharmaceutical drug and medicine development services; design for others in the field of drugs and medicines; development of pharmaceutical preparations and medicines; professional consultancy pertaining to pharmacology, namely, biotechnical and biomedical and medical and pharmaceutical substances, preparations and compounds; professional consultancy in the field of research and development of medicine and the dispensing of pharmaceutical preparations; pharmaceutical drug development services comprised of scientific, industrial, technological, bio technical, pharmaceutical, biomedical and clinical research in the field of drugs and drug candidates; medical and scientific research, namely, conducting clinical trials of new drug candidates; consultation in the field of scientific research pertaining to chemical, pharmaceutical and medical goods; design for others in the field of medical packaging and equipment; development of pharmaceutical preparations and medicines; consultation in the field of biotechnological and biomedical scientific research; biochemical and molecular biological analyses; in vitro and in vivo preclinical tests and clinical tests of drug candidates and potential drugs; consultancy and research regarding pharmaceuticals in gel-like and viscous liquid dosage forms; consultancy and research pertaining to pharmacology in the nature of alternative drugs for the young, elderly and those with difficulties swallowing pills and tablets; development of in vitro and in vivo preclinical tests of drug candidates and potential drugs; biochemical and molecular biological analyses; scientific, industrial, technological and biotechnological analysis in the field of pharmaceutical and veterinary drug and medicine analysis, analysis of drug delivery apparatus and containers, analysis of synthetic peptides for pharmaceutical purposes, analysis of peptide substrates, analysis for the purpose of detecting various toxins, analysis of drug candidates and potential drugs |
| FOREGIN REGISTRATION | |
| Foreign Filing Date | 03/03/2005 |
|---|---|
| Foreign Registration Date | 03/29/2006 |
| Foreign Expiration Date | 03/03/2015 |
| Foreign Application Number | 004320041 |
| Country | EM |
| Foreign Registration Number | 004320041 |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 08/20/2011 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
| 08/29/2012 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | I - Incoming Correspondence | DP1B - 1(B) BASIS DELETED; PROCEED TO REGISTRATION | |
| 08/15/2012 | NOTICE OF ALLOWANCE CANCELLED | S | IUCN - NOTICE OF ALLOWANCE CANCELLED | |
| 08/15/2012 | TEAS DELETE 1(B) BASIS RECEIVED | I - Incoming Correspondence | D1BR - TEAS DELETE 1(B) BASIS RECEIVED | |
| 02/22/2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 02/21/2012 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
| 02/10/2012 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
| 02/10/2012 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 08/23/2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 08/17/2011 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
| 08/17/2011 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 02/26/2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 02/25/2011 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
| 02/23/2011 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
| 02/23/2011 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 10/13/2010 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | I - Incoming Correspondence | ASGN | |
| 09/09/2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 09/08/2010 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
| 08/23/2010 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
| 08/23/2010 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 01/30/2010 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
| 12/21/2009 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
| 01/29/2010 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
| 12/21/2009 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 08/25/2009 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
| 06/02/2009 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 05/13/2009 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
| 04/28/2009 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 04/27/2009 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 04/04/2009 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 04/04/2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 04/01/2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 10/08/2008 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 10/08/2008 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
| 10/08/2008 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 09/12/2008 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 09/12/2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 09/11/2008 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 02/27/2006 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 09/09/2005 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
| 09/11/2008 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 03/11/2008 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 03/11/2008 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
| 03/11/2008 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 02/06/2008 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 02/05/2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 02/05/2008 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | I - Incoming Correspondence | ERSI | |
| 11/26/2007 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS2 | |
| 11/26/2007 | INQUIRY TO SUSPENSION E-MAILED | S | GNSI - INQUIRY TO SUSPENSION E-MAILED | |
| 11/26/2007 | SUSPENSION INQUIRY WRITTEN | R - Renewal | CNSI - SUSPENSION INQUIRY - COMPLETED | |
| 11/06/2007 | LIE CHECKED SUSP - TO ATTY FOR ACTION | S | RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION | |
| 05/04/2007 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 05/04/2007 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 10/25/2006 | LETTER OF SUSPENSION E-MAILED | S | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 10/25/2006 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
| 10/03/2006 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 10/03/2006 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 10/02/2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 10/02/2006 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 03/30/2006 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 03/30/2006 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 03/16/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 02/15/2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 02/15/2006 | TEAS VOLUNTARY AMENDMENT RECEIVED | I - Incoming Correspondence | PARI - TEAS PRELIMINARY AMENDMENT RECEIVED | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.